Gliclazide and Minitran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gliclazide (gliclazide) and Minitran (nitroglycerin). Common drug interactions include asthma among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Gliclazide and Minitran. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.

On Jul, 15, 2026

18 people who take Gliclazide and Minitran together, and have interactions are studied.

Gliclazide and Minitran drug interactions.

What are the common drug interactions of Gliclazide and Minitran, by gender? *:

female:

Asthma
Cardiac failure congestive
Chest discomfort
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Cough
Crepitations (noises are produced by the rubbing of parts one against the other)
Dizziness
Dyspnoea (difficult or laboured respiration)
Fall

male:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block complete (heart block complete)
Bradycardia (abnormally slow heart action)
Hypotension (abnormally low blood pressure)
Confusional state
Gait disturbance
Hypokalaemia (low potassium)
Sopor (sleep)

What are the common drug interactions of Gliclazide and Minitran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Acute myocardial infarction (acute heart attack)
Adverse drug reaction
Dyspnoea (difficult or laboured respiration)
Fall
Glaucoma (increased fluid pressure in the eye with vision loss)
Haemorrhage (bleeding)
Limb injury
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Oedema peripheral (superficial swelling)
Peripheral vascular disorder

What are the existing conditions these people have? *

Asthma: 6 people, 33.33%
High Blood Pressure: 3 people, 16.67%
Dyslipidaemia (abnormal amount of lipids): 2 people, 11.11%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 11.11%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 2 people, 11.11%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.56%
Allergic Rhinitis: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and Minitran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously